Savings Potential With Biosimilars : vimarsana.com

Jonathan Kay, MD, and Kimberly C. Chen DO, MSHLM, define what a biosimilar is and discuss the potential for a lower cost than the reference product.

Related Keywords

Jonathan Kay , Kimberlyc Chen , , Biosimilars Stakeholder Summit , Interchangeable Biosimilars , Inflammatory Diseases , Biosimilar , Reference Product , Lower Cost , Pharmacokinetics , Clinical Trial , Efficacy , Immunogenicity , Immunogenic ,